Aldeyra Therapeutics, Inc. 4
4 · Aldeyra Therapeutics, Inc. · Filed Mar 7, 2017
Insider Transaction Report
Form 4
Clark David J
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-03-03+155,656→ 155,656 totalExercise: $5.10Exp: 2027-03-02→ Common Stock (155,656 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2017.